Bibliography

ACPO Drugs Committee (2002), A review of drugs policy and proposals for the future, The Association of Chief Police Officers, London.

Bossong, M.G., Van Dijk, J.P. and Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), pp. 321–3.

Burrell, K., Jones, L., Sumnall, H. et al. (2005), Tiered approach to drug prevention and treatment among young people, National Collaborating Centre for Drug Prevention, Liverpool.

Chen, C.-Y., O’Brien, M.S. and Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001’, Drug and alcohol dependence 79, pp. 11–22.

Chivite-Matthews, N., Richardson, A., O’Shea, J. et al. (2005), Drug misuse declared: findings from the 2003/04 British Crime Survey. Home Office statistical bulletin 04/05, Home Office, London (http://www.homeoffice.gov.uk/rds/pdfs05/hosb0405.pdf).

CND (2005), World drug situation with regard to drug trafficking: Report of the Secretariat, Commission on Narcotic Drugs, United Nations Economic and Social Council, Vienna.

CND (2006), World drug situation with regard to drug trafficking: Report of the Secretariat, Commission on Narcotic Drugs, United Nations Economic and Social Council, Vienna.

EMCDDA (2002a), Prosecution of drug users in Europe – varying pathways to similar objectives, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

EMCDDA (2002b), 'Mortality of drug users in the EU: coordination of implementation of new cohort studies, follow-up and analysis of existing cohorts and development of new methods and outputs', Project CT.00.EP.13, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

EMCDDA (2004a), 2004 Annual report on the drugs problem in the European Union and Norway, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

EMCDDA (2004b), An overview of cannabis potency in Europe, Insights no. 6, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

EMCDDA (2004c), European report on drug consumption rooms, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

EMCDDA (2004d), 'Overdose: a major cause of avoidable death among young people', Drugs in Focus No. 13, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

EMCDDA (2005a), Annual report 2005: the state of the drugs problem in Europe, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

EMCDDA (2005b),'Assistance to EMCDDA for the analysis of drug profiles from EMCDDA Databank on surveys of drug use', final report, project CT.03.P1.200, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

EMCDDA (2005c), 'Data collection to develop an inventory of social and health policies, measures and actions concerning drug users in prison in the recently incorporated Member States to the EU', final report, project CT.04.P2.329, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

EuroHIV (2005), HIV/AIDS surveillance in Europe: End-year report 2004. Institute de veille sanitaire: Saint-Maurice. No 71.

Europol (2006), 'Drugs 2006' (communication to the EMCDDA of 16 January 2006, file no. 158448), Europol, The Hague.

Farrell, M., Gowing, L., Marsden, J. et al. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, pp. S67–75.

Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), 'Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users', World psychiatry 4(3), pp. 173–6.

Hibell, B., Andersson, B., Bjarnasson, T. et al. (2004), The ESPAD report 2003: alcohol and other drug use among students in 35 European countries, The Swedish Council for Information on Alcohol and Other Drugs (CAN) and Council of Europe Pompidou Group.

Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, pp. 1043–52.

INCB (2006a), Report of the International Narcotics Control Board for 2005, United Nations International Narcotics Control Board, New York.

INCB (2006b), Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances, United Nations International Narcotics Control Board, New York.

Kandel, D. and Davis, M. (1992), 'Progression to regular marijuana involvement: Phenomenology and risk factors fro near daily use', in: Glantz, M. and Pickens, R. (eds), Vulnerability to Drug Abuse pp. 211–53. American Psychological Association. Washington.

Kumpfer, K.L., Molgaard, V. and Spoth, R. (1996), 'The Strengthening Families Program for prevention of delinquency and drug use in special populations', in: Peters, R. and McMahon, R. J. (eds) Childhood disorders, substance abuse, and delinquency: prevention and early intervention approaches, Sage Publications, Newbury Park, CA.

MacDonald, Z., Tinsley, L., Collingwood, J. et al. (2005), Measuring the harm from illegal drugs using the drug harm index. Home Office Online Report 24/05. Home Office, London (http://www.homeoffice.gov.uk/rds/pdfs05/rdsolr2405.pdf).

Naber, D. and Haasen, C. (2006), Das bundesdeutsche Modellprojekt zur heroingestützten Behandlung Opiatabhängiger – eine multizentrische, randomisierte, kontrollierte Therapiestudie, Hamburg: Zentrum für interdisziplinäre Suchtforschung der Universität Hamburg (http://www.heroinstudie.de/ZIS_H-Bericht_P1_DLR.pdf).

ONS (2006), Health Statistics Quarterly 29, Office for National Statistics, London.

Poling, J., Oliveto, A., Petry, N. et al. (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, pp. 219–28.

Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), 'Cocaine use in Europe – a multi-centre study: patterns of use in different groups', European addiction research 10, pp.147–55.

Reitox national reports (2005) (http://www.emcdda.europa.eu/?nnodeid=435).

Roe, E. and Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), pp. 85–99.

Roozen, H.G., Boulogne, J.J., van Tulder, M.W. et al. (2004), ‘A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, pp. 1–13.

Schäfer, C. and Paoli, L. (2006), Drogenkonsum und Strafverfolgungspraxis, Duncker & Humblot, Berlin.

Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. et al. (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, pp. 340–9.

Shearer, J. and Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, pp. 203–11.

UNODC (2003a), Global illicit drug trends 2003, United Nations Office on Drugs and Crime, Vienna.

UNODC (2003b), Ecstasy and amphetamines: global survey 2003, United Nations Office on Drugs and Crime, Vienna.

UNODC (2005), Coca cultivation in the Andean region: A survey of Bolivia, Colombia and Peru – June 2005, United Nations Office on Drugs and Crime, Vienna.

UNODC (2006), 2006 world drug report, United Nations Office on Drugs and Crime, Vienna.

UNODC and Government of Morocco (2005), Morocco Cannabis Survey 2004. United Nations Office on Drugs and Crime, Vienna.

Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), pp. 196–8.

Vickerman, P., Hickman, M., Rhodes, T. and Watts, C. (2006), ‘Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users’, Journal of Acquired Immune Deficiency Syndromes (in press).

Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), pp. 49–64.

WCO (2005), Customs and drugs 2004, World Customs Organization, Brussels.

WHO (2005), Effectiveness of drug dependence treatment in preventing HIV among injecting drug users. Evidence for action technical papers, World Health Organization, Geneva.

WHO/UNODC/UNAIDS (2004), 'Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention', position paper, World Health Organization, United Nations Office on Drugs and Crime, UNAIDS (http://www.who.int/substance_abuse/publications/treatment/en/index.html).